Skip to main content

Advertisement

Log in

Predicting surgical site infections following laparoscopic bariatric surgery: development of the BariWound tool using the MBSAQIP database

  • 2019 SAGES Oral
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Although bariatric surgery is a safe procedure for severe obesity, incisional surgical site infections (SSI) remain a significant cause of morbidity. Bariatric surgery patients are at high risk due to obesity and diabetes. The objective of this study was to develop a predictive tool for incisional SSI within 30 days of bariatric surgery.

Methods

Data were retrieved from the 2015 and 2016 MBSAQIP databases. This study included patients who underwent primary laparoscopic Roux-en-Y gastric bypass (LRYGB) or laparoscopic sleeve gastrectomy (LSG). The primary outcome of interest was incisional SSI occurring within 30 days. Surgeries performed in 2015 were used in a derivation cohort and the predictive tool was validated against the 2016 cohort. A forward selection algorithm was used to build a logistic regression model predicting probability of SSI.

Results

A total of 274,187 patients were included with 71.7% being LSG and 28.3% LRYGB. 0.7% of patients had a SSI in which 71.0% had an incisional SSI, and 29.9% had an organ/space SSI. Of patients who had an incisional SSI, 88.7% were superficial, 10.9% were deep, and 0.4% were both. A prediction model to assess for risk of incisional SSI, BariWound, was derived and validated. BariWound consists of procedure type, chronic steroid or immunosuppressant use, gastroesophageal reflux disease, obstructive sleep apnea, sex, type 2 diabetes, hypertension, operative time, and body mass index. It stratifies individuals into very high (> 10%), high (5–10%), medium (1–5%), and low risk (< 1%) groups. This model accurately predicted events in the validation cohort with an area under the receiver operating characteristic curve of 0.73.

Conclusions

BariWound accurately predicted the risk of 30-day incisional SSI in individuals undergoing bariatric surgery. Stratifying low- and high-risk groups allows for customized SSI prophylactic measures for patients in various risk categories and potentially enables future research targeted at high-risk patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Angrisani L, Santonicola A, Iovino P, Vitiello A, Higa K, Himpens J, Buchwald H, Scopinaro N (2018) IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. https://doi.org/10.1007/s11695-018-3450-2

    Article  PubMed  Google Scholar 

  2. Freeman JT, Anderson DJ, Hartwig MG, Sexton DJ (2011) Surgical site infections following bariatric surgery in community hospitals: a weighty concern? Obes Surg 21:836–840. https://doi.org/10.1007/s11695-010-0105-3

    Article  PubMed  Google Scholar 

  3. Winfield RD, Reese S, Bochicchio K, Mazuski JE, Bochicchio GV (2016) Obesity and the risk for surgical site infection in abdominal surgery. Am Surg 82:331–336

    PubMed  Google Scholar 

  4. Thelwall S, Harrington P, Sheridan E, Lamagni T (2015) Impact of obesity on the risk of wound infection following surgery: results from a nationwide prospective multicentre cohort study in England. Clin Microbiol Infect 21:1008.e1–1008.e8. https://doi.org/10.1016/J.CMI.2015.07.003

    Article  CAS  Google Scholar 

  5. Martin ET, Kaye KS, Knott C, Nguyen H, Santarossa M, Evans R, Bertran E, Jaber L (2016) Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 37:88–99. https://doi.org/10.1017/ice.2015.249

    Article  PubMed  Google Scholar 

  6. Shope TR, Cooney RN, McLeod J, Miller CA, Haluck RS (2003) Early results after laparoscopic gastric bypass: EEA vs GIA stapled gastrojejunal anastomosis. Obes Surg 13:355–359. https://doi.org/10.1381/096089203765887651

    Article  PubMed  Google Scholar 

  7. Alasfar F, Sabnis A, Liu R, Chand B (2010) Reduction of circular stapler-related wound infection in patients undergoing laparoscopic Roux-en-Y gastric bypass, Cleveland clinic technique. Obes Surg 20:168–172. https://doi.org/10.1007/s11695-008-9708-3

    Article  PubMed  Google Scholar 

  8. Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J (2000) Outcomes after laparoscopic roux-en-Y gastric bypass for morbid obesity. Ann Surg 232:515–529. https://doi.org/10.1097/00000658-200010000-00007

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Finks JF, Carlin A, Share D, Oreilly AN, Fan Z, Birkmeyer J, Birkmeyer N (2011) Effect of surgical techniques on clinical outcomes after laparoscopic gastric bypass—results from the Michigan Bariatric Surgery Collaborative for the Michigan Bariatric Surgery Collaborative from the Michigan Surgical Collaborative for Outcomes Research Evaluation. SOARD 7:284–289. https://doi.org/10.1016/j.soard.2010.10.004

    Article  Google Scholar 

  10. Shabino PJ, Khoraki J, Elegbede AF, Schmocker RK, Nabozny MJ, Funk LM, Greenberg JA, Campos GM (2016) Reduction of surgical site infections after laparoscopic gastric bypass with circular stapled gastrojejunostomy. Surg Obes Relat Dis 12:4–9. https://doi.org/10.1016/J.SOARD.2015.03.003

    Article  PubMed  Google Scholar 

  11. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR (1999) Guideline for prevention of surgical site infection, 1999. Am J Infect Control 27:97–134. https://doi.org/10.1016/S0196-6553(99)70088-X

    Article  CAS  PubMed  Google Scholar 

  12. Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, Fish DN, Napolitano LM, Sawyer RG, Slain D, Steinberg JP, Weinstein RA (2013) Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 14:73–156. https://doi.org/10.1089/sur.2013.9999

    Article  Google Scholar 

  13. Anderson DJ, Podgorny K, Berríos-Torres SI, Bratzler DW, Dellinger EP, Greene L, Nyquist A-C, Saiman L, Yokoe DS, Maragakis LL, Kaye KS (2014) Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 35:S66–S88. https://doi.org/10.1017/S0899823X00193869

    Article  PubMed  Google Scholar 

  14. Chopra T, Zhao JJ, Alangaden G, Wood MH, Kaye KS (2010) Preventing surgical site infections after bariatric surgery: value of perioperative antibiotic regimens. Expert Rev Pharmacoecon Outcomes Res 10:317–328. https://doi.org/10.1586/erp.10.26

    Article  PubMed  PubMed Central  Google Scholar 

  15. MBSAQIP Standards Manual. https://www.facs.org/quality-programs/mbsaqip/standards. Accessed 24 Jul 2017

  16. Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N (2015) Bariatric Surgery Worldwide 2013. Obes Surg 25:1822–1832. https://doi.org/10.1007/s11695-015-1657-z

    Article  CAS  PubMed  Google Scholar 

  17. StataCorp (2015) Stata Statistical Software

  18. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Obuchowski N, Pencina MJ, Kattan MW (2010) Assessing the performance of prediction models: a framework for some traditional and novel measures. Epidemiology 21:128–138. https://doi.org/10.1097/EDE.0b013e3181c30fb2.Assessing

    Article  PubMed  PubMed Central  Google Scholar 

  19. Madan AK, Harper JL, Tichansky DS (2008) Techniques of laparoscopic gastric bypass: on-line survey of American Society for Bariatric Surgery practicing surgeons. Surg Obes Relat Dis 4:166–172. https://doi.org/10.1016/j.soard.2007.08.006

    Article  PubMed  Google Scholar 

  20. Kaplan JA, Schecter SC, Rogers SJ, Lin MYC, Posselt AM, Carter JT (2017) Expanded indications for bariatric surgery: should patients on chronic steroids be offered bariatric procedures? Surg Obes Relat Dis 13:35–40. https://doi.org/10.1016/j.soard.2015.10.086

    Article  PubMed  Google Scholar 

  21. De Vivo A, Mancuso A, Giacobbe A, Priolo AM, De Dominici R, Savasta LM (2010) Wound length and corticosteroid administration as risk factors for surgical-site complications following cesarean section. Acta Obstet Gynecol Scand 89:355–359. https://doi.org/10.3109/00016340903568175

    Article  PubMed  Google Scholar 

  22. Falagas ME, Kompoti M (2006) Obesity and infection. Lancet Infect Dis 6:438–446

    Article  PubMed  Google Scholar 

  23. Mancuso P (2013) Obesity and respiratory infections: does excess adiposity weigh down host defense? Pulm Pharmacol Ther 26:412–419. https://doi.org/10.1016/j.pupt.2012.04.006

    Article  CAS  PubMed  Google Scholar 

  24. Schneid-Kofman N, Sheiner E, Levy A, Holcberg G (2005) Risk factors for wound infection following cesarean deliveries. Int J Gynecol Obstet 90:10–15. https://doi.org/10.1016/j.ijgo.2005.03.020

    Article  CAS  Google Scholar 

  25. Fernandez AZ, Demaria EJ, Kellum JM, Sugerman HJ (2004) Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg 239:698–703. https://doi.org/10.1097/01.sla.0000124295.41578.ab

    Article  PubMed  PubMed Central  Google Scholar 

  26. Theisen J, Nehra D, Citron D, Johansson J, Hagen JA, Crookes PF, DeMeester SR, Bremner CG, DeMeester TR, Peters JH (2000) Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg 4:50–54. https://doi.org/10.1016/S1091-255X(00)80032-3

    Article  CAS  PubMed  Google Scholar 

  27. Finan KR, Vick CC, Kiefe CI, Neumayer L, Hawn MT (2005) Predictors of wound infection in ventral hernia repair. Am J Surg 190:676–681. https://doi.org/10.1016/j.amjsurg.2005.06.041

    Article  PubMed  Google Scholar 

  28. Peersman G, Laskin R, Davis J, Peterson MGE, Richart T (2005) Prolonged operative time correlates with increased infection rate after total knee arthroplasty. HSS J 2:70–72. https://doi.org/10.1007/s11420-005-0130-2

    Article  Google Scholar 

  29. Beldame J, Lagrave B, Lievain L, Lefebvre B, Frebourg N, Dujardin F (2012) Surgical glove bacterial contamination and perforation during total hip arthroplasty implantation: when gloves should be changed. Orthop Traumatol Surg Res 98:432–440. https://doi.org/10.1016/j.otsr.2011.10.015

    Article  CAS  PubMed  Google Scholar 

  30. Giefing-Kröll C, Berger P, Lepperdinger G, Grubeck-Loebenstein B (2015) How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell 14:309–321. https://doi.org/10.1111/acel.12326

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jerry T. Dang.

Ethics declarations

Disclosure

Jerry T. Dang, Caroline Tran, Noah Switzer, Megan Delisle, Michael Laffin, Karen Madsen, Daniel W. Birch, and Shahzeer Karmali have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appendix: definitions

Appendix: definitions

Variable name: superficial incisional SSI


Intent of variable To capture the occurrence of infection that does not meet the more severe criteria of deep incisional SSI or organ/space SSI.


Definition Superficial incisional SSI is an infection that involves only skin or subcutaneous tissue of the surgical incision.


Criteria An infection that occurs within 30 days after the principal operative procedure AND the infection involves only skin or subcutaneous tissue of the incision AND at least ONE of the following:

  1. A.

    Purulent drainage, with or without laboratory confirmation, from the superficial incision.

  2. B.

    Organisms isolated from an aseptically obtained culture of fluid or tissue from the superficial incision.

  3. C.

    Superficial incision is deliberately opened by the surgeon (see note below)

AND


At least one of the following signs or symptoms of infection:

  • pain or tenderness

  • localized swelling

  • redness

  • heat

If the patient meets criterion C and the surgical incision is cultured, a negative culture result would exclude the assignment of Superficial SSI based on criterion C only.

  1. D.

    Diagnosis of superficial incisional SSI by the surgeon or attending physician.

Variable name: deep incisional SSI


Intent of variable To capture the occurrence of infection that does not meet the criteria of superficial incisional SSI or organ/space SSI. These infections are typically more severe than the superficial SSI category.


Definition Deep Incisional SSI is an infection which involves deep soft tissues. Deep soft tissues are typically any tissue beneath skin and immediate subcutaneous fat, for example fascial and muscle layers.


Criteria An infection that occurs at the surgical site within 30 days after the principal operative procedure AND involves deep soft tissues AND at least ONE of the following:

  1. A.

    Purulent drainage from the deep incision but not from the organ/space component of the surgical site.

  2. B.

    A deep incision spontaneously dehisces or is deliberately opened by a surgeon when the patient has at least one of the following signs or symptoms: fever (greater than 38 °C), localized pain, or tenderness, unless the site is culture-negative.

  3. C.

    An abscess or other evidence of infection involving the deep incision is found on direct examination, during reoperation, or by histopathologic or radiologic examination.

  4. D.

    Diagnosis of a deep incision SSI by a surgeon or attending physician.

Variable name: organ/space SSI


Intent of variable To capture the occurrence of infection that does not meet the criteria of superficial incisional SSI or deep incisional SSI. This category of infection is typically the most severe and is more likely to require procedural intervention.


Definition Organ/Space SSI is an infection that involves any part of the anatomy (e.g., organs or spaces), other than the incision, which was opened or manipulated during an operation.


Criteria An infection that occurs within 30 days after the principal operative procedure AND involves any of the anatomy (e.g., organs or spaces), other than the incision, which was opened or manipulated during the operation AND at least ONE of the following:

  1. A.

    Purulent drainage from a drain that is placed through a stab wound into the organ/space. This does not apply to drains placed during the principal operative procedure, which are continually in place, with continual evidence of drainage/infection since the time of the principal operative procedure.

  2. B.

    Organisms isolated from an aseptically obtained culture of fluid or tissue in the organ/space.

  3. C.

    An abscess or other evidence of infection involving the organ/space that is found on direct examination, during reoperation, or by histopathologic or radiologic examination.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dang, J.T., Tran, C., Switzer, N. et al. Predicting surgical site infections following laparoscopic bariatric surgery: development of the BariWound tool using the MBSAQIP database. Surg Endosc 34, 1802–1811 (2020). https://doi.org/10.1007/s00464-019-06932-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-019-06932-6

Keywords

Navigation